The latest news
OS Therapies Targets September Approval for Osteosarcoma Drug with FDA Filing
Rockville, Tuesday, 3 February 2026.
The company initiated its regulatory filing for OST-HER2. Approval by September would secure a Priority Review Voucher, recently valued at $200 million, adding significant financial upside.
latest news in economy
Market Volatility Spikes as Precious Metals Plunge and Tech Jitters Weigh on Futures
New York, Monday, 2 February 2026.
United States stock futures are retreating this Monday as a historic sell-off in gold and silver deepens, with silver plummeting significantly following a margin requirement hike by CME Group. The nomination of Kevin Warsh as Fed Chair has strengthened the dollar, unraveling the ‘debasement trade’ and triggering widespread volatility that is now spilling over into technology stocks amid renewed AI skepticism.
latest news in companies
Analyst Forecasts Palantir Shares to Hit $200 Ahead of Today's Earnings Report
New York, Monday, 2 February 2026.
William Blair upgraded Palantir to Outperform today, setting a $200 price target. This implies a massive 36% upside potential just hours before the company releases its fourth-quarter earnings.
latest news in politics
latest news in global
latest news in general
NASA Targets February 8 for Historic Artemis II Lunar Mission Launch
Cape Canaveral, Sunday, 1 February 2026.
NASA targets February 8 for Artemis II. This historic mission ends a 54-year hiatus in lunar exploration, carrying the first non-American astronaut, Canada’s Jeremy Hansen, beyond low Earth orbit.